Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice

Over one billion people have received 2–3 dosages of an inactivated COVID-19 vaccine for basic immunization. Whether a booster dose should be delivered to protect against the Omicron variant and its sub-lineages, remains controversial. Here, we tested different vaccine platforms targeting the ancest...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Jianyang Liu, Qian He, Fan Gao, Lianlian Bian, Qian Wang, Chaoqiang An, Lifang Song, Jialu Zhang, Dong Liu, Ziyang Song, Lu Li, Yu Bai, Zhongfang Wang, Zhenglun Liang, Qunying Mao, Miao Xu
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Taylor & Francis Group 2023-12-01
Serie:	Emerging Microbes and Infections
Ämnen:	COVID-19 Omicron variant booster vaccine neutralizing antibody heterologous vaccination
Länkar:	https://www.tandfonline.com/doi/10.1080/22221751.2022.2143283
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!